Antimicrobial Susceptibility Testing Market worth 3.47 Billion USD by 2022
The global Antimicrobial Susceptibility Testing Market is expected to reach USD 3.47 Billion by 2022 from USD 2.71 Billion in 2017, at a CAGR of 5.1%. The major factors driving the growth of the antimicrobial susceptibility testing (AST) market include the rising prevalence of infectious diseases; increased funding, research grants, and public-private investments; and technological advancements...
Technological Advancements Towards the Development of Rapid Antimicrobial susceptibility testing (AST) Methods
Factors such as increasing prevalence of infectious diseases across the globe, emergence of antimicrobial resistance caused due to drug overuse, increasing initiatives by government organizations towards improving the detection and control antimicrobial resistant species, and improving growth opportunities in emerging markets are boosting the demand for antimicrobial susceptibility testing products.
...